Testing effectiveness (Phase 2)Study completedNCT01644877
What this trial is testing
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 111